Oral Wegovy Pill: No More Injections for Weight Loss?

Last updated: 4 June 2026 | Medically reviewed content — always consult your doctor

For millions of people who want the weight loss benefits of Wegovy but hate needles, January 2026 brought game-changing news: the oral Wegovy pill was FDA-approved in the United States, becoming the first GLP-1 weight loss tablet on the market.

Same active ingredient (semaglutide). Same powerful results. No injection required. In clinical trials, the Wegovy pill delivered 14–17% body weight loss over 64 weeks — matching the injectable version that has already transformed the weight loss landscape.

Here's everything South Africans need to know about the oral Wegovy pill: how it works, what the clinical data shows, how it compares to the injection, when it might reach SA, and what it could cost in rands.

What Is the Oral Wegovy Pill?

The oral Wegovy pill is a once-daily tablet containing semaglutide — the same GLP-1 receptor agonist found in injectable Wegovy and Ozempic. Novo Nordisk developed a special formulation that protects the semaglutide peptide from being destroyed by stomach acid, allowing it to be absorbed through the stomach lining.

The approved dose for weight loss is 25mg taken once daily. For context, injectable Wegovy delivers 2.4mg once weekly — the oral dose is higher because only a small fraction of the tablet's semaglutide is absorbed through the stomach.

Key fact: The oral Wegovy pill uses the same SNAC (sodium N-[8-(2-hydroxybenzoyl) amino] caprylate) absorption enhancer technology proven in Rybelsus (oral semaglutide for type 2 diabetes), but at a much higher dose optimised specifically for weight loss.

How Does It Work?

Like all semaglutide products, the Wegovy pill works by mimicking the GLP-1 hormone your body naturally produces after eating:

The difference is simply the delivery method: a daily pill instead of a weekly injection. The end result in your body is the same.

Clinical Trial Results: The OASIS Programme

The oral Wegovy pill was tested in Novo Nordisk's extensive OASIS clinical trial programme, which enrolled thousands of participants across multiple countries. Here are the headline results:

OASIS 4 — The Pivotal Weight Loss Trial (25mg Dose)

This was the trial that led directly to FDA approval. It enrolled 307 adults with obesity or overweight plus at least one weight-related condition (excluding diabetes).

Outcome Oral Wegovy 25mg Placebo
Average weight loss (all participants) 13.6% 2.4%
Average weight loss (on-treatment) 16.6% 2.7%
Achieved ≥10% weight loss ~60% <10%
Achieved ≥20% weight loss ~30% <3%
Trial duration 64 weeks

OASIS 1 — The Higher Dose Trial (50mg)

An earlier trial tested the 50mg dose in adults with overweight or obesity:

OASIS 2 — East Asian Population (50mg)

Bottom line: Whether at 25mg or 50mg, oral semaglutide delivers weight loss results that match or come very close to the injectable version. The 25mg dose was chosen for the initial approval because it offered the best balance of efficacy and tolerability.

Oral Wegovy Pill vs Injectable Wegovy: Head-to-Head Comparison

This is the question every South African considering Wegovy wants answered: should you wait for the pill, or start with the injection?

Feature Oral Wegovy Pill Injectable Wegovy
Active ingredient Semaglutide Semaglutide
Dose 25mg daily 2.4mg weekly
How taken Daily pill, empty stomach Weekly injection (pen)
Average weight loss 13–15% ~15%
Food timing 30-min fast after taking No restrictions
Storage Room temperature Refrigerated (before first use)
Needles None Yes (auto-injector pen)
US price (2026) ~$299/month (R5,400) ~$349/month (R6,300)
SA availability Not yet (est. 2027-2028) Available now (~R3,700/month)

Who Might Prefer the Pill?

Who Might Prefer the Injection?

How to Take the Oral Wegovy Pill

The Wegovy pill has specific dosing instructions that must be followed carefully for it to work properly:

  1. Take it first thing in the morning on a completely empty stomach
  2. Swallow whole with no more than 120ml of plain water (about half a glass)
  3. Do not crush, chew, or split the tablet
  4. Wait at least 30 minutes before eating, drinking anything else, or taking other medications
  5. After the 30-minute window, eat normally — enjoy your morning rooibos tea and breakfast
Why the strict routine? Semaglutide is a peptide (a small protein) that stomach acid and food can break down. The SNAC absorption enhancer in the tablet needs a brief window in an empty, low-acid stomach to shuttle semaglutide through the stomach lining. Taking it with food or too much water dramatically reduces absorption and effectiveness.

Dosing Schedule

Like injectable Wegovy, the oral version uses a gradual dose escalation to minimise side effects:

Phase Dose Duration
Starting dose 1.5mg daily 4 weeks
Escalation 1 3.5mg daily 4 weeks
Escalation 2 7mg daily 4 weeks
Escalation 3 14mg daily 4 weeks
Maintenance dose 25mg daily Ongoing

Side Effects of the Oral Wegovy Pill

The side effect profile is similar to injectable semaglutide, with gastrointestinal symptoms being the most common, particularly during dose escalation:

Side Effect Oral Wegovy Placebo
Any GI side effect 74% 42%
Nausea ~45% ~15%
Vomiting ~31% ~6%
Diarrhoea ~25% ~12%
Constipation ~15% ~8%
Decreased appetite ~20% ~5%
Serious adverse events 3.9% 8.8%
Good news: Most GI side effects were mild to moderate and occurred primarily during the dose escalation phase. Nausea typically lasted less than two weeks, and vomiting episodes generally resolved within a few days. Serious adverse events were actually less common with oral Wegovy (3.9%) than with placebo (8.8%).

To minimise side effects, follow the gradual dose escalation schedule and consider these practical tips:

How Does the Wegovy Pill Compare to Other Oral Weight Loss Medications?

The oral Wegovy pill is not the only weight loss pill on the horizon. Here's how it stacks up against the competition:

Drug Company Type Weight Loss Status (June 2026)
Oral Wegovy (semaglutide 25mg) Novo Nordisk GLP-1 agonist 14–17% FDA approved (Jan 2026)
Orforglipron (Foundayo) Eli Lilly GLP-1 agonist (small molecule) ~11% FDA approved (Apr 2026)
Amycretin Novo Nordisk GLP-1/amylin dual agonist ~13% (Phase 1) Phase 2 trials
Danuglipron Pfizer GLP-1 agonist (small molecule) 8–13% Discontinued (liver safety signal)
Key distinction: Oral Wegovy is a peptide-based GLP-1 pill (requires the SNAC absorption technology and strict fasting), while orforglipron is a small molecule that can be taken with or without food. Each approach has trade-offs — oral Wegovy has stronger weight loss data, while orforglipron offers more convenient dosing.

When Will the Oral Wegovy Pill Be Available in South Africa?

As of June 2026, the oral Wegovy pill is not yet available in South Africa. Here's the current timeline:

Milestone Status
FDA approval (USA) Approved — January 2026
US commercial launch Available — early 2026
EMA submission (Europe) Under review
Rybelsus (oral semaglutide for diabetes) SA registration Registered by SAHPRA (2024) but not launched
Injectable Wegovy SA availability Available — up to R3,700/month
Oral Wegovy SAHPRA submission Not announced
Estimated SA availability 2027–2028 (estimated)

What South Africans Can Do Right Now

While waiting for the oral Wegovy pill:

Estimated South African Pricing

While there's no confirmed SA pricing for the oral Wegovy pill, we can make informed estimates based on US pricing and existing SA pricing for related products:

Product US Price (2026) SA Price / Estimate
Oral Wegovy pill (25mg daily) ~$299/month R4,000–R6,000/month (est.)
Injectable Wegovy (2.4mg weekly) ~$349/month Up to R3,700/month
Ozempic (1mg weekly) ~$950/month R2,500–R3,500/month
Mounjaro (15mg weekly) ~$1,060/month R3,500–R5,000/month
Important: These SA price estimates are speculative and based on current exchange rates and Novo Nordisk's existing SA pricing strategy. Actual prices will be determined by SAHPRA's Single Exit Price mechanism and Novo Nordisk's local pricing decisions. Prices may be significantly different when the product launches.

Should You Wait for the Pill or Start Injections Now?

This is a very personal decision that depends on your circumstances. Here's a framework to help you decide:

Consider starting injectable Wegovy now if:

Consider waiting for the pill if:

Always consult your doctor before starting any weight loss medication. GLP-1 medications are prescription-only and not suitable for everyone. Your doctor can help you weigh the risks and benefits based on your individual health profile, including conditions like potential side effects and weight regain considerations.

The Bigger Picture: Oral GLP-1s Are Just the Beginning

The oral Wegovy pill represents a turning point in weight loss medicine. For the first time, the most effective class of weight loss drugs is available without injections. But the pipeline doesn't stop here:

The future of weight management in South Africa is moving rapidly from weekly injections to daily pills — and eventually to even more convenient options. The key is working with your doctor to find the approach that fits your lifestyle, budget, and health needs.

Stay Updated on Weight Loss Medications in South Africa

New weight loss drugs are reaching SA faster than ever. Bookmark this page for updates on the oral Wegovy pill's SA availability, or explore our guides to medications available right now:

Wegovy (Injectable) | Ozempic | Mounjaro | Wegovy vs Mounjaro | All Weight Loss Injections